Clinical studies in liver transplantation;Klinische Studien in der Lebertransplantation

Chirurg

Volumn 71, Issue 6, 2000, Pages 667-675

  Kohlhaw, K ^a,b   Schwarz, R ^a   Lubke P ^a   Hartwig, Th ^a   Berr, F ^a   Hauss, J ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b Klin F Abdom Thorax E   (Germany)

Author keywords

Clinical liver transplantation; Clinical studies; Immunosuppressants; Surgical techniques

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CYTOMEGALIC INCLUSION BODY DISEASE; DOUBLE BLIND PROCEDURE; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVER TUMOR; METHODOLOGY; MULTICENTER STUDY; POSTOPERATIVE COMPLICATION; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

CARCINOMA, HEPATOCELLULAR; CYCLOSPORINE; CYTOMEGALOVIRUS INFECTIONS; DOUBLE-BLIND METHOD; HEPATITIS B; HEPATITIS C; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MULTICENTER STUDIES; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; TACROLIMUS;

EID: 0034198643     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001040051118     Document Type: Article

References (68)

1. Bechstein WO, Guckelberger O, Kling N, Rayes N, et al (1998) Recurrence-free survival after liver transplantation for small hepatocellular carcinoma. Transpl Int 11: 189
2. Belli LS, de Carlis L, Rondinara G, Alberti Ab, et al (1998) Early cyclosporine monotherapy in liver transplantation: a 5-year follow-up of a prospective, randomized trial. Hepatology 27: 1524
3. Bismuth H, Houssin D (1984) Reduced-sized orthotopic liver graft in hepatic transplantation in children. Surgery 95: 367
4. Bismuth H, Chiche L, Adam R, Castaing D, et al (1993) Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 218: 145
5. Broelsch CE, Whitington PF, Emond JC, Heffron TG, et al (1991) Liver transplantation in children from living related donors. Surgical techniques and results. Ann Surg 214: 428
6. Busuttil RW, Goss JA (1999) Split liver transplantation. Ann Surg 229: 313
7. Calne RY, Williams R (1968) Liver transplantation in man. I. Observations on technique and organization in five cases. Br Med J 30: 535
8. Calne RY, Rolles K, White DJ, Thiru S, et al (1979) Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet 8151: 1033
9. Calne RY, White DJ (1982) The use of cyclosporin A in clinical organ grafting. Ann Surg 196: 330
10. Cattral MS, Hemming AW, Wanless IR, Al Ashgar H, et al (1999) Outcome of long-term ribavirin therapy for recurrent hepatitis C after liver transplantation. Transplantation 67: 1277
11. Chan CY, DasGupta K, Baker AL (1996) Cyclosporin A: drug discontinuation for the management of long-term toxicity after liver transplantation. Hepatology 24: 1085
12. Cherqui D, Piedbois P, Pierga JY, Duvoux C, et al (1994) Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma. A pilot study. Cancer 73: 2721
13. Cohen AT, O'Grady JG, Sutherland S, Sallie R, et al (1993) Controlled trial of prophylactic versus therapeutic use of ganciclovir after liver transplantation in adults. J Med Virol 40: 5
14. Davidson BR, Rai R, Kurzawinski TR, Selves L, et al (1999) Prospective randomized trial of end-to-end versus side-to-side biliary reconstruction after orthotopic liver transplantation. Br J Surg 86: 447
15. Emond JC, Whitington PF, Broelsch CE (1991) Overview of reduced-size liver transplantation. Clin Transplant 5: 168
16. Fisher RA, Ham JM, Marcos A, Shiffman ML, et al (1998) A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantation. Transplantation 66: 1616
17. Grande L, Rimola A, Cugat E, Alvarez L, et al (1996) Effect of venovenous bypass on perioperative renal function in liver transplantation: results of a randomized, controlled trial. Hepatology 23: 1418
18. Harnois DM, Steers J, Andrews JC, Rubin JC, et al (1999) Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma. Liver Transpl Surg 5: 192
19. Iwatsuki S, Todo S, Marsh JW, Madariaga JR, et al (1998) Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg 187: 358
20. Jain AB, Hamad I, Rakela J, Dodson F, et al (1998) A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim report. Transplantation 66: 1395
21. Jain A, Reyes J, Kashyap R, Rohal S, et al (1999) What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients. Ann Surg 230: 441
22. Jonas S, Rayes N, Neumann U, Neuhaus R, et al (1997) De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin. Cancer 80: 1141
23. Jonas S, Guckelberger O, Bechstein WO, et al (1998) Five-year follow-up of tacrolimus as primary immunosuppressant after liver transplantation. Transplant Proc 30: 2179
24. Jonas S, Kling N, Guckelberger O, Keck H (1998) Orthotopic liver transplantation after extended bile duct resection as treatment of hilar cholangiocarcinoma. First long-terms results. Transpl Int 11 [Suppl 1]: 206
25. Jovine E, Mazziotti A, Grazi GL, Ercolani G, et al (1997) Piggy-back versus conventional technique in liver transplantation: report of a randomized trial. Transpl Int 10: 109
26. Keck H, Langrehr JM, Knoop M, Lohmann R, et al (1995) Reconstruction of bile duct using the side-to-side anastomosis in 389 orthotopic liver transplantations. Transplant Proc 27: 1250
27. Klein A (1999) Tacrolimus rescue in liver transplant patients with refractory rejection or intolerance or malabsorption of cyclosporine. The US Multicenter FK506 Liver Study Group. Liver Transpl Surg 5: 502
28. Klein M, Geoghegan J, Wangemann R, Bockler D, et al (1999) Preconditioning of donor livers with prostaglandin I2 before retrieval decreases hepatocellular ischemia-reperfusion injury. Transplantation 67: 1128
29. Klintmalm GB (1998) Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg 228: 479
30. Langrehr JM, Guckelberger O, Neumann U, Berg T, et al (1997) Liver transplantation in HBsAg + patients with post-operative immunoprophylaxis. Transplant Proc 29: 2841
31. Langrehr JM, Nussler NC, Neumann U, Guckelberger O, et al (1997) A prospective randomized trial comparing interleukin-2 receptor antibody versus antithymocyte globulin as part of a quadruple immunosuppressive induction therapy following orthotopic liver transplantation. Transplantation 63: 1772
32. Langrehr JM, Glanemann M, Guckelberger O, Klupp J, et al (1998) A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantation. Clin Transplant 12: 303
33. Lerut JP, Molle G, Donataccio M, De Kock M, et al (1997) Cavocaval liver transplantation without venovenous bypass and without temporary portocaval shunting: the ideal technique for adult liver. Transpl Int 10: 171
34. McDiarmid SV, Farmer DA, Goldstein LI, Martin P, et al (1995) A randomized prospective trial of steroid withdrawal after liver transplantation. Transplantation 60: 1443
35. Nashan B, Schlitt HJ, Schwinzer R, Ringe B, et al (1996) Immunoprophylaxis with a monoclonal anti-IL-2 receptor antibody in liver transplant patients. Transplantation 61: 546
36. Neuhaus P, Langrehr JM, Williams R, Calne RY, et al (1997) Tacrolimus-based immunosuppression after liver transplantation: a randomised study comparing dual versus low-dose oral regimens. Transpl Int 10: 253
37. Neumann UP, Kaisers U, Langrehr JM, Glanemann M, et al (2000) Administration of prostacyclin after liver transplantation: a placebo controlled randomized trial. Clin Transplant 14: 70
38. Oldhafer K, Haller GW, Kattner A, Winkler M, et al (1996) Absorption of cyclosporine Neoral early after liver transplantation: influence of bile on oral absorption. Transplant Proc 28: 2237
39. Oldhafer KJ, Chavan A, Fruhauf NR, Flemming P, et al (1998) Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit? J Hepatol 29: 953
40. Olthoff KM, Rosove MH, Shackleton CR, Imagawa DK, et al (1995) Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma. Ann Surg 221: 734
41. Otte JB, de Ville de Goyet J, Reding R, et al (1998) Pediatric liver transplantation: from the full-size liver graft to reduced, split, and living related liver transplantation. Pediatr Surg Int 13: 308
42. Otto MG, Mayer AD, Clavien PA, Cavallari A, et al (1998) Randomized trial of cyclosporine microemulsion (neoral) versus conventional cyclosporine in liver transplantation: MILTON study. (Multicentre International Study in Liver Transplantation of Neoral.) Transplantation 66: 1632
43. Parrilla P, Sanchez-Bueno F, Figueras J, Jaurrieta E, et al (1999) Analysis of the complications of the piggy-back technique in 1,112 liver transplants.Transplantation 67: 1214
44. Penn I (1996) Posttransplantation de novo tumors in liver allograft recipients. Liver Transpl Surg 2: 52
45. Perrillo R, Rakela J, Dienstag J, Levy G, et al (1999) Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group. Hepatology 29: 1581
46. Pichlmayr R, Ringe B, Gubernatis G, Hauss J, Bunzendahl H (1988) Transplantation of a donor liver to 2 recipients (splitting transplantation) - a new method in the further development of segmental liver transplantation. Langenbecks Arch Chir 373: 127
47. Pratschke J, Neuhaus R, Tullius SG, Haller GW, et al (1997) Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation. Transplantation 64: 938
48. Raia S, Nery JR, Mies S (1989) Liver transplantation from live donors. Lancet 8661: 497
49. Rayes N, Seehofer D, Bechstein WO, Muller AR, et al (1999) Long-term results of famciclovir for recurrent or de novo hepatitis B virus infection after liver transplantation. Clin Transplant 13: 447
50. Reyes J, Gerber D, Mazariegos GV, Casavilla A, et al (2000) Split-liver transplantation: a comparison of ex vivo and in situ techniques. J Pediatr Surg 35: 283
51. Ringe B, Wittekind C, Bechstein WO, Bunzendahl H, Pichlmayr R (1989) The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg 209: 88
52. Ringe B, Burdelski M, Rodeck B, Pichlmayr R (1990) Experience with partial liver transplantation in Hannover. Clin Transpl 5: 135
53. Rogiers X, Malago M, Habib N, Knoefel WT, et al (1995) In situ splitting of the liver in the heart-beating cadaveric organ donor for transplantation in two recipients. Transplantation 59: 1081
54. Rogiers X, Malago M, Nollkemper D, Sterneck M, et al (1997) The Hamburg liver transplant program. Clin Transpl 12: 183
55. Rolles K, Davidson BR, Burroughs AK (1999) A pilot study of immunosuppressive monotherapy in liver transplantation: tacrolimus versus microemulsified cyclosporin Transplantation 68: 1195
56. Rossi G, Langer M, Maggi U, Reggiani P, et al (1998) Veno-venous bypass versus no bypass in orthotopic liver transplantation: hemodynamic, metabolic, and renal data. Transplant Proc 30: 1871
57. Samuel D, Bismuth A, Mathieu D, Arulnaden JL, et al (1991) Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Lancet 8745: 813
58. Samuel D, Muller R, Alexander G, Fassati L, et al (1993) Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 329: 1842
59. Singh N, Gayowski T, Wannstedt CF, Shakil AO, et al (1998) Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients: a prospective, randomized, controlled trial. Transplantation 65: 82
60. Snydman DR, Werner BG, Dougherty NN, Griffith J, et al (1993) Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled rial. The Boston Center for Liver Transplantation CMVIG Study Group. Ann Intern Med 119: 984
61. Stone MJ, Klintmalm GB, Polter D, Husberg BS, et al (1993) Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients. Gastroenterology 104: 196
62. Terrault NA, Holland CC, Ferrell L, Hahn JA, et al (1996) Interferon alfa for recurrent hepatitis B infection after liver transplantation. Liver Transpl Surg 2: 132
63. Terrault NA, Wright TL (1997) Hepatitis B virus infection and liver transplantation. Gut 40: 568
64. Wiesner RH (1998) A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group. Transplantation 66: 493
65. Winkler M, Ringe B, Jost U, Melter M, et al (1993) Conversion from cyclosporin to FK 506 after liver transplantation. Transpl Int 6: 319
66. Winkler M, Haller G, Oldhafer K, Bechstein WO, et al (1996) A new oral formulation of cyclosporine for early oral immunosuppressive therapy in liver transplant recipients. Transplantation 62: 1063
67. Winston DJ, Wirin D, Snaked A, Busuttil RW (1995) Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients. Lancet 8967: 69
68. Wonigeit K, Hoyer PF, Schumann G, Ringe B, et al (1986) Experiences with a blood level-adjusted cyclosporine regimen in kidney and liver allograft recipients. Transplant Proc 18: 181